TOKYO -- In an unorthodox move for a Japanese pharmaceutical company, Shionogi & Co. has begun to foster personnel with information technology skills for new drug development.
IT specialists are fairly rare in the drug sector, and Shionogi Director and Senior Executive Officer Takuko Sawada readily admits that her company has also been late to digitize its drug discovery efforts.
